ロード中...
Prophylactic Surgery: For Whom, When and How?
Risk-reducing surgery has proved to be a reasonable procedure in healthy women with a definitely elevated risk of developing cancer. Here we consider the elevated risk of breast and ovarian cancer. There is a clear indication for such surgery in healthy women with a pathogenic BRCA1/2 mutation. For...
保存先:
| 出版年: | Breast Care (Basel) |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger GmbH
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5803721/ https://ncbi.nlm.nih.gov/pubmed/29456469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000485830 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|